Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Rating) was the target of a significant drop in short interest in July. As of July 31st, there was short interest totalling 81,900 shares, a drop of 9.9% from the July 15th total of 90,900 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 73,100 shares, the days-to-cover ratio is currently 1.1 days.
Analyst Ratings Changes
CCAP has been the subject of a number of research reports. Raymond James decreased their price objective on Crescent Capital BDC from $21.00 to $20.50 and set an “outperform” rating for the company in a report on Friday, August 12th. Oppenheimer raised Crescent Capital BDC from a “market perform” rating to an “outperform” rating and reduced their price target for the company from $20.00 to $19.00 in a research report on Friday, August 12th. Finally, Wells Fargo & Company reduced their price target on Crescent Capital BDC from $19.50 to $18.50 and set an “overweight” rating for the company in a research report on Monday, April 25th.
Crescent Capital BDC Stock Performance
Shares of CCAP traded down $0.03 during mid-day trading on Wednesday, reaching $17.92. The company’s stock had a trading volume of 942 shares, compared to its average volume of 48,038. Crescent Capital BDC has a 1-year low of $15.06 and a 1-year high of $21.48. The stock has a market cap of $553.55 million, a P/E ratio of 11.89, a PEG ratio of 0.86 and a beta of 0.89. The business has a 50-day simple moving average of $16.30 and a two-hundred day simple moving average of $17.19. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 1.02.
Crescent Capital BDC Dividend Announcement
Institutional Trading of Crescent Capital BDC
Hedge funds have recently made changes to their positions in the business. Virtus ETF Advisers LLC lifted its holdings in Crescent Capital BDC by 9.7% during the 4th quarter. Virtus ETF Advisers LLC now owns 18,653 shares of the company’s stock worth $328,000 after purchasing an additional 1,651 shares during the last quarter. UBS Group AG lifted its holdings in Crescent Capital BDC by 48.2% during the 1st quarter. UBS Group AG now owns 6,645 shares of the company’s stock worth $118,000 after purchasing an additional 2,160 shares during the last quarter. Cowen Prime Advisors LLC bought a new position in Crescent Capital BDC during the 2nd quarter worth $47,000. Raymond James & Associates increased its stake in Crescent Capital BDC by 8.4% during the 4th quarter. Raymond James & Associates now owns 45,471 shares of the company’s stock worth $800,000 after acquiring an additional 3,508 shares during the period. Finally, HighTower Advisors LLC increased its stake in Crescent Capital BDC by 5.7% during the 1st quarter. HighTower Advisors LLC now owns 184,285 shares of the company’s stock worth $3,281,000 after acquiring an additional 9,923 shares during the period. 54.76% of the stock is owned by institutional investors and hedge funds.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States.
- Get a free copy of the StockNews.com research report on Crescent Capital BDC (CCAP)
- Lowe’s Stands Out Amid Q2 Retail Reports
- Agilent Technologies Proves Its Worth VS Illumina
- Target’s Results Cap Upside Potential For Retail Stocks
- Are These 3 Video Game Stocks Now In Play?
- 2 Long-Term EV Plays Trading Under $20
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.